1. Home
  2. Clinical Topics
  3. FDA approves head lice treatment
Clinical TopicsDrugs and DevicesHealthcare & TechnologyNewsPediatricsWeb Exclusives

FDA approves head lice treatment

Share

The U.S. Food and Drug Administration has approved Natroba (spinosad) Topical Suspension 0.9% for the treatment of head lice in patients 4 years and older. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm240302.htm.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Poll

Recent Posts